The Ochsner Medical Center in New Orleans and its Gayle and Tom Benson Cancer Center are leading the way in cancer care, research, and education in the region. As one of the largest medical facilities in the southeast, Ochsner is an important source of multi-disciplinary treatment and clinical trials. The center offers expert care for the many people in the Gulf region who have been impacted by asbestos in the shipping and oil industries. [13]
The most promising mesothelioma treatment option is a multimodal combination of surgery, chemotherapy, and radiation therapy. Some patients may benefit from emerging treatments, like immunotherapy. Supportive and palliative treatments relieve symptoms and improve quality of life.
Brigham and Women’s Hospital in Boston is a premier cancer center in its own right, but it also partners with other medical centers, including the Dana-Farber Cancer Institute, to provide the best care. The hospital is home to the International Mesothelioma Program, which is devoted to developing the newest and most effective treatments for pleural mesothelioma. The program treats nearly 200 patients each year, and research here led to the development of the innovative and aggressive extrapleural pneumonectomy surgical technique. This unique surgery has extended the lives of numerous pleural mesothelioma patients. [6]
Dr. Daniel Sterman, M.D. is a physician with numerous jobs and titles at New York University’s Langone Medical Center. A specialist in pulmonary diseases, Dr. Sterman works with patients diagnosed with pleural mesothelioma. He combines research and clinical care to provide better patient treatment and advance medical knowledge of mesothelioma and other malignancies. Education and
Raphael Bueno, M.D. is a thoracic surgeon and serves as Chief of the Division of Thoracic Surgery and Vice-Chair of Surgery for Cancer and Translational Research at Brigham and Women’s Hospital in Boston. Dr. Bueno also directs the hospital’s International Mesothelioma Program. He is dedicated to maintaining Brigham and Women’s world-leading place in mesothelioma treatment
A leading mesothelioma expert, David Jablons, M.D., studied under distinguished mentor Dr. Sugarbaker of Sloan Kettering Memorial, a recognized leader in mesothelioma cancer treatment. Today, Dr. Jablons is a teacher, researcher, and surgeon at the University of California, San Francisco. Education Dr. Jablons earned his undergraduate degree in American literature. He then attended Albany Medical College
Dr. Anne Tsao is a medical oncologist and expert in mesothelioma treatment. She currently holds several positions at the MD Anderson Cancer Center in Houston, Texas, including associate professor, director of the Mesothelioma Program, and director of the Thoracic Chemo-Radiation Program. Dr. Tsao also participates in research and helps match patients to clinical trials. Education
Hedy Lee Kindler, M.D. is a gastrointestinal oncologist at the University of Chicago Comprehensive Cancer Center where she is an associate professor of medicine. She directs the Gastrointestinal Oncology Program there as well as the Mesothelioma Program. Dr. Kindler has contributed to many research projects focusing on mesothelioma and other cancers and organizes clinical trials
Joseph Friedberg, M.D. is a board-certified surgeon specializing in thoracic cancers, including pleural mesothelioma, lung cancer, and lung-sparing surgeries. Dr. Friedberg is the Thoracic Surgeon-in-Chief at Temple University Health Systems and Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. Education Dr. Friedberg completed his undergraduate studies at the University of Pennsylvania College of
Raja Flores, M.D. is chief of Thoracic Surgery at Mount Sinai Medical Center and director of the Thoracic Surgical Oncology Program at Mount Sinai Cancer Center. He is a world-famous cardiothoracic surgeon with expertise in pleural mesothelioma, esophageal cancer, and lung cancer. His landmark work in surgical mesothelioma treatment changed the way surgeons approach this